477 COM902 (Anti-TIGIT antibody) monotherapy – preliminary evaluation of safety, tolerability, pharmacokinetics and receptor occupancy in patients with advanced solid tumors (NCT04354246)

Ecaterina Dumbrava; Drew Rasco; Amita Patnaik; Daniel Vaena; Kyriakos Papadopoulos; Adam ElNaggar; Adeboye Adewoye; Robina Smith; Pierre Ferré; Ilan Vaknin; Srinivas Devarakonda; Manish Sharma

doi:10.1136/jitc-2021-SITC2021.477

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

477 COM902 (Anti-TIGIT antibody) monotherapy – preliminary evaluation of safety, tolerability, pharmacokinetics and receptor occupancy in patients with advanced solid tumors (NCT04354246)

Free

Authors

Ecaterina Dumbrava MDACC, Houston, TX, USA PubMed articles Google scholar articles
Drew Rasco START – San Antonio., San Antonio, TX, USA PubMed articles Google scholar articles
Amita Patnaik START – San Antonio., San Antonio, TX, USA PubMed articles Google scholar articles
Daniel Vaena West Cancer Center and Rsch Institute., Memphis, TN, USA PubMed articles Google scholar articles
Kyriakos Papadopoulos START – San Antonio., San Antonio, TX, USA PubMed articles Google scholar articles
Adam ElNaggar West Cancer Center and Rsch Institute., Memphis, TN, USA PubMed articles Google scholar articles
Adeboye Adewoye Compugen USA Inc., San Francisco, USA PubMed articles Google scholar articles
Robina Smith Compugen USA Inc., San Francisco, USA PubMed articles Google scholar articles
Pierre Ferré Compugen USA Inc., San Francisco, USA PubMed articles Google scholar articles
Ilan Vaknin Compugen USA Inc., San Francisco, USA PubMed articles Google scholar articles
Srinivas Devarakonda Ohio State University, Columbus, OH, USA PubMed articles Google scholar articles
Manish Sharma START – Midwest., Grand Rapids, MI, USA PubMed articles Google scholar articles

Citation

Dumbrava E, Rasco D, Patnaik A, et al

477 COM902 (Anti-TIGIT antibody) monotherapy – preliminary evaluation of safety, tolerability, pharmacokinetics and receptor occupancy in patients with advanced solid tumors (NCT04354246)

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.477

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password